carbidopa has been researched along with Chronic Illness in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (56.25) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azam, A; Azam, B; Jensen, DB; Wienecke, J; Zhang, M | 1 |
Breitenstein, C; Flöel, A; Heuschmann, P; Knecht, S; Rösser, N; Wersching, H | 1 |
Hurka, MR; Leopold, NA; Polansky, M | 1 |
Brusa, L; Finazzi-Agrò, E; Iani, C; Miano, R; Moschella, V; Petta, F; Pisani, A; Stanzione, P | 1 |
Chuang, LW; Karoum, F; Liebowitz, MR; Murphy, DL; Potkin, S; Wyatt, RJ | 1 |
Kraus, MF; Maki, P | 1 |
Alexander, MP | 1 |
Caine, ED; Davis, GC; Ebert, MH; Kopin, IJ; Markey, SP; Reichert, CM; Williams, AC | 1 |
Bigelow, LB; Gillin, JC; Walls, P; Wyatt, RJ | 1 |
Brambilla, F; Guastalla, A; Maffei, C; Nobile, P; Ponzano, M; Rovere, C; Scarone, S | 1 |
Rózga, J; Szczerbań, J | 1 |
Joly, P; Lampert, A; Lauret, P; Thomine, E | 1 |
Ludatscher, JI | 1 |
Elias, JW; Hutton, JT; Imke, SC; Morris, JL; Román, GC | 1 |
Adamkov, J; Fundárek, J; Sútorová, D | 1 |
Ballard, PA; Langston, JW; Tetrud, JW | 1 |
6 trial(s) available for carbidopa and Chronic Illness
Article | Year |
---|---|
Levodopa improves procedural motor learning in chronic stroke patients.
Topics: Aged; Carbidopa; Chronic Disease; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Female; Germany; Humans; Levodopa; Male; Middle Aged; Motor Skills; Placebos; Reaction Time; Statistics, Nonparametric; Stroke; Stroke Rehabilitation; Treatment Outcome | 2008 |
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
Topics: Acute Disease; Carbidopa; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypogastric Plexus; Levodopa; Male; Middle Aged; Parasympathetic Fibers, Postganglionic; Parkinson Disease; Synaptic Transmission; Treatment Outcome; Urinary Bladder; Urinary Bladder, Neurogenic; Urination Disorders | 2007 |
Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1979 |
Catecholaminergic drugs in chronic schizophrenia.
Topics: Adult; Apomorphine; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrazines; Imipramine; Levodopa; Luteinizing Hormone; Male; Middle Aged; Placebos; Schizophrenia, Disorganized; Testosterone | 1979 |
Stable remission of tardive dyskinesia by L-dopa.
Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia | 1989 |
Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa.
Topics: Aged; Carbidopa; Chronic Disease; Delayed-Action Preparations; Disability Evaluation; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1988 |
10 other study(ies) available for carbidopa and Chronic Illness
Article | Year |
---|---|
Spinal Cord Hemisection Facilitates Aromatic L-Amino Acid Decarboxylase Cells to Produce Serotonin in the Subchronic but Not the Chronic Phase.
Topics: 5-Hydroxytryptophan; Animals; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Chronic Disease; Hindlimb; Male; Nerve Fibers; Neuronal Plasticity; Neurons; Rats; Rats, Sprague-Dawley; Serotonin; Spinal Cord Injuries; Tail; Thoracic Vertebrae | 2015 |
Drug adherence in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Chronic Disease; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Female; Humans; Levodopa; Male; Medication Systems; Parkinson Disease; Patient Compliance; Surveys and Questionnaires | 2004 |
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
Topics: Carbidopa; Chronic Disease; Clorgyline; Depressive Disorder; Female; Humans; Male; Pargyline; Phenethylamines; Phenylacetates; Phenylalanine; Schizophrenia; Schizophrenia, Paranoid | 1984 |
The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury.
Topics: Amantadine; Behavior; Brain Injuries; Carbidopa; Chronic Disease; Cognition; Drug Therapy, Combination; Female; Humans; Levodopa; Mental Status Schedule; Middle Aged; Neuropsychological Tests | 1997 |
Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.
Topics: Adult; Akinetic Mutism; Carbidopa; Cerebral Infarction; Chronic Disease; Diencephalon; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Neuropsychological Tests; Pergolide | 2001 |
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
Topics: Adult; Bromocriptine; Carbidopa; Chronic Disease; Humans; Levodopa; Locus Coeruleus; Male; Meperidine; Opioid-Related Disorders; Parkinson Disease, Secondary; Substantia Nigra | 1979 |
Treatment of acute and chronic portal encephalopathy with the precursors of dopamine.
Topics: Acute Disease; Adolescent; Adult; Aged; Carbidopa; Chronic Disease; Hepatic Encephalopathy; Humans; Middle Aged | 1979 |
Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Chronic Disease; Depression; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Humans; Male; Parkinson Disease; Scleroderma, Localized | 1991 |
[Neurologic and electromyographic findings in chronic manganese encephalopathy].
Topics: Adult; Brain Diseases; Carbidopa; Chronic Disease; Drug Combinations; Electromyography; Humans; Levodopa; Male; Manganese Poisoning; Metallurgy; Middle Aged; Occupational Diseases | 1986 |
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra | 1985 |